TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD

NYSE · Pharmaceutical Preparations

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Teva Pharmaceutical Industries develops, manufactures, and sells generic and branded pharmaceuticals, including treatments for conditions such as multiple sclerosis, migraine, and Parkinson's disease, as well as active pharmaceutical ingredients and biosimilars sold worldwide.

Industry

Pharmaceutical Preparations

Headquarters

Tel Aviv

Exchange

NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
Savage BrianInterim Chief Legal Officer	Sell	$174K	4,503at $38.69	Sep 18, 2026
Savage BrianInterim Chief Legal Officer	Sell	$99K	2,525at $39.15	Sep 18, 2026
Savage BrianInterim Chief Legal Officer	Sell	$12K	314at $38.70	Sep 18, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

Member	Chamber	Type	Amount	Date
Alan ArmstrongArmstrong, Alan (Senator)	Senate	Buy	$1,001 - $15,000	Mar 30, 2026

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable TEVA activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

Mobile number (optional)

SMS is optional: we only save your number if you check the consent box and provide a valid number. Outside US/Canada, include + and your country code.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.